Data Insights
By Company Name
No filters selected
By Disease Name
No filters selected
By Drug Name
No filters selected
By Themes
No filters selected
Showing 1 results out of 1
Data Insights
GSK-3888130 by GSK for Multiple Sclerosis: Likelihood of Approval
GSK-3888130 is under clinical development by GSK and currently in Phase I for Multiple Sclerosis. According to GlobalData, Phase I...